Translational Centers Using Microphysiologic Systems for Infectious Diseases
Funds translational centers building human microphysiologic systems — engineered tissue platforms — for infectious disease drug and biologic development.
Most microphysiologic systems — engineered platforms that mimic how a tissue or organ actually behaves, sometimes called organ-on-a-chip systems — have been built for cancer or toxicology. Almost none have been built for infectious disease, and this notice exists to close that gap.
The goal is accelerating the use of these systems for infectious disease research and for developing therapeutics or…
Development and translational use of human microphysiologic systems — in vitro platforms mimicking physiological tissue or organ function — specifically for infectious disease research and the development of therapeutics or biological products, aimed at adoption by drug and biologic developers and acceptance in regulatory pathways at the Food and Drug Administration.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up